Plastic and Reconstructive Surgery
Dr. Mary Walton
The number of cosmetic breast implant surgeries performed yearly has steadily increased since their introduction in the 1960s, with hundreds of thousands of implantations performed annually. With the increasing frequency of these procedures and a history of questionable patient safety, clinicians treating these patients should be well-informed on the associated risks of breast implantation. Although breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) has been well described, a 2022 FDA news release advises of an additional associated neoplastic process now known as breast implant-associated squamous cell carcinoma (BIA-SCC). This article aims to educate clinicians on BIA-ALCL and BIA-SCC for use when treating patients considering implantation and post-operative care.
Pesa K. Breast Implant-Associated Neoplasms: A Review and Update. Lynchburg Journal of Medical Science. 2023; 5(1).
Available when accessing via a campus IP address or logged in with a University of Lynchburg email address.
Off-campus users can also use 'Off-campus Download' button above for access.